| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Tyrosine-protein kinase JAK1 [837-1142] |
|---|
| Ligand | BDBM400615 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | In Vitro JAK Kinase Assay |
|---|
| IC50 | <5±n/a nM |
|---|
| Citation |  Huang, T; Xue, C Piperidin-4-yl azetidine derivatives as JAK1 inhibitors US Patent US11285140 Publication Date 3/29/2022 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Tyrosine-protein kinase JAK1 [837-1142] |
|---|
| Name: | Tyrosine-protein kinase JAK1 [837-1142] |
|---|
| Synonyms: | JAK1 | JAK1 (aa 837-1142) | JAK1A | JAK1B | JAK1_HUMAN | Tyrosine-protein kinase JAK1 | Tyrosine-protein kinase JAK1 (837-1142) | Tyrosine-protein kinase JAK1 (aa 837-1142) |
|---|
| Type: | n/a |
|---|
| Mol. Mass.: | 35230.04 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P23458[837-1142] |
|---|
| Residue: | 306 |
|---|
| Sequence: | FFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDP
EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM
EFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ
VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT
YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQP
SNRTSF
|
|
|
|---|
| BDBM400615 |
|---|
| n/a |
|---|
| Name | BDBM400615 |
|---|
| Synonyms: | US10695337, Example 371 | US11285140, Example 371 | US9999619, Example 371 | {1-(1-{[6-[(methylamino)methyl]-2-(trifluoromethyl)pyrimidin-4-yl]carbonyl}piperidin-4-yl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile trifluoroacetate salt |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C27H28F3N11O |
|---|
| Mol. Mass. | 579.5795 |
|---|
| SMILES | CNCc1cc(nc(n1)C(F)(F)F)C(=O)N1CCC(CC1)N1CC(CC#N)(C1)n1cc(cn1)-c1ncnc2[nH]ccc12 |
|---|
| Structure | 
|
|---|
Search and Browse
